Verbatim response from ChatGPT
Short answer
- Ask your clinician about Zepbound (tirzepatide) if your main goal is the largest average weight loss and you’re willing to accept a higher chance of GI side effects and a newer drug with less long‑term real‑world data.
- Ask about Wegovy (semaglutide) if you prefer an option with a longer market track‑record for weight management and broad prescriber experience — it’s still very effective for most people.
Both require a prescription and a medical evaluation to decide which is safer/better for you.
Why I’m recommending those
- Zepbound (Eli Lilly; active = tirzepatide) — in clinical trials tirzepatide produced larger mean weight loss than semaglutide at approved doses. It’s once‑weekly and tends to be the more potent option for many people, but it is newer for obesity treatment and can cause nausea, diarrhea, vomiting and other GLP‑1/GIP class side effects.
- Wegovy (Novo Nordisk; active = semaglutide 2.4 mg) — once‑weekly, widely used for obesity with more cumulative clinical experience and manufacturer support programs. It’s very effective for many people and has a well‑understood side‑effect profile (mainly GI).
Key medical considerations (talk these over with your provider)
- Contraindications/shared precautions: pregnancy/planning pregnancy, history of medullary thyroid carcinoma or MEN2, active pancreatitis, certain GI disorders, and some drug interactions. Dose must be titrated slowly to reduce GI side effects.
- Both are injectable once weekly but use different active drugs/doses — Zepbound dosing is titrated up to higher weekly doses (discuss exact schedule with your prescriber); Wegovy’s maintenance dose is 2.4 mg weekly after titration.
Where to get them online
- Start with your primary care physician, endocrinologist, or a local weight‑management clinic — they can evaluate you and write a prescription for either drug.
- Manufacturer resources: both Eli Lilly (Zepbound) and Novo Nordisk (Wegovy) have patient support/hub programs and information on how to find providers and savings options (you’ll need a prescription to enroll).
- Telehealth companies that commonly evaluate people for GLP‑1 or tirzepatide prescriptions (examples you can consider): Hims & Hers, Ro (Roman), and GoodRx Health. These services offer virtual visits, and if appropriate, will prescribe and send the prescription to a pharmacy or specialty/mail-order pharmacy.
- Pharmacies: most major pharmacy chains (CVS, Walgreens, Walmart) and large retail/specialty/mail‑order pharmacies will fill Wegovy or Zepbound with a valid prescription. Specialty pharmacy handling is common for these biologic injectables.
- Before you buy/check out: verify insurance coverage and prior‑authorization requirements (many plans require PA), compare out‑of‑pocket costs, and ask about manufacturer copay or savings programs.
If you want, I can:
- Help draft questions to ask your clinician.
- Check typical out‑of‑pocket cost estimates if you tell me your insurance type (Medicare/private/no insurance).
- Walk you through what to expect in a telehealth consult and how to compare a few telehealth vendors. Which of those would you like next?